Thermo Fisher Scientific Life Sciences Solutions — Cost of revenues increased by 6.0% to $961.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.0%, from $907.00M to $961.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease relative to revenue indicates improved manufacturing efficiency or better pricing power, while an increase suggests rising input costs.
The direct costs attributable to the production and delivery of goods sold by the Life Sciences Solutions segment, inclu...
Standard metric for all manufacturing and product-based business segments.
tmo_segment_life_sciences_solutions_cost_of_revenues| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $1.02B | $1.02B | $1.02B | $1.02B | $907.00M | $961.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -11.0% | +6.0% |
| YoY Change | — | — | — | — | -11.0% | +6.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.